Loading…

Single nucleotide polymorphisms (SNPs) in prostate cancer: its implications in diagnostics and therapeutics

Prostate cancer is one of the most frequently diagnosed malignancies in developed countries and approximately 248,530 new cases of prostate cancer are likely to be diagnosed in the United States in 2021. During the late 1990s and 2000s, the prostate cancer-related death rate has decreased by 4% per...

Full description

Saved in:
Bibliographic Details
Published in:American journal of translational research 2021-01, Vol.13 (4), p.3868-3889
Main Authors: Allemailem, Khaled S, Almatroudi, Ahmad, Alrumaihi, Faris, Makki Almansour, Nahlah, Aldakheel, Fahad M, Rather, Rafiq Ahmad, Afroze, Dil, Rah, Bilal
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 3889
container_issue 4
container_start_page 3868
container_title American journal of translational research
container_volume 13
creator Allemailem, Khaled S
Almatroudi, Ahmad
Alrumaihi, Faris
Makki Almansour, Nahlah
Aldakheel, Fahad M
Rather, Rafiq Ahmad
Afroze, Dil
Rah, Bilal
description Prostate cancer is one of the most frequently diagnosed malignancies in developed countries and approximately 248,530 new cases of prostate cancer are likely to be diagnosed in the United States in 2021. During the late 1990s and 2000s, the prostate cancer-related death rate has decreased by 4% per year on average because of advancements in prostate-specific antigen (PSA) testing. However, the non-specificity of PSA to distinguish between benign and malignant forms of cancer is a major concern in the management of prostate cancer. Despite other risk factors in the pathogenesis of prostate cancer, recent advancement in molecular genetics suggests that genetic heredity plays a crucial role in prostate carcinogenesis. Approximately, 60% of heritability and more than 100 well-recognized single-nucleotide-polymorphisms (SNPs) have been found to be associated with prostate cancer and constitute a major risk factor in the development of prostate cancer. Recent findings revealed that a low to moderate effect on the progression of prostate cancer of individual SNPs was observed compared to a strong progressive effect when SNPs were in combination. Here, in this review, we made an attempt to critically analyze the role of SNPs and associated genes in the development of prostate cancer and their implications in diagnostics and therapeutics. A better understanding of the role of SNPs in prostate cancer susceptibility may improve risk prediction, enhance fine-mapping, and furnish new insights into the underlying pathophysiology of prostate cancer.
format article
fullrecord <record><control><sourceid>pubmed</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8129253</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>34017579</sourcerecordid><originalsourceid>FETCH-LOGICAL-p266t-b711eea6d60be38a455279853c6f949d30162b97bb2003539502768820178763</originalsourceid><addsrcrecordid>eNpVkEtLAzEUhYMotlb_gmSpi4E8Ji8XghRfUFRo90Mmk7bRmSQkqdB_b4sP6upc7jn3g3uOwBirmlYS1_j4YB6Bs5zfEeJMcXIKRrRGWDChxuBj7vyqt9BvTG9DcZ2FMfTbIaS4dnnI8Gr-8pavofMwppCLLhYa7Y1NN9CVDN0Qe2d0ccHnfahzeuV3OWcy1L6DZW2TjnazX5yDk6Xus7340QlYPNwvpk_V7PXxeXo3qyLhvFStwNhazTuOWkulrhkjQklGDV-qWnUUYU5aJdqWIEQZVQwRwaUku5-k4HQCbr-xcdMOtjPWl6T7JiY36LRtgnbNf8e7dbMKn43ERBFGd4DLQ8Df5W9r9AtLbGvo</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Single nucleotide polymorphisms (SNPs) in prostate cancer: its implications in diagnostics and therapeutics</title><source>PMC (PubMed Central)</source><creator>Allemailem, Khaled S ; Almatroudi, Ahmad ; Alrumaihi, Faris ; Makki Almansour, Nahlah ; Aldakheel, Fahad M ; Rather, Rafiq Ahmad ; Afroze, Dil ; Rah, Bilal</creator><creatorcontrib>Allemailem, Khaled S ; Almatroudi, Ahmad ; Alrumaihi, Faris ; Makki Almansour, Nahlah ; Aldakheel, Fahad M ; Rather, Rafiq Ahmad ; Afroze, Dil ; Rah, Bilal</creatorcontrib><description>Prostate cancer is one of the most frequently diagnosed malignancies in developed countries and approximately 248,530 new cases of prostate cancer are likely to be diagnosed in the United States in 2021. During the late 1990s and 2000s, the prostate cancer-related death rate has decreased by 4% per year on average because of advancements in prostate-specific antigen (PSA) testing. However, the non-specificity of PSA to distinguish between benign and malignant forms of cancer is a major concern in the management of prostate cancer. Despite other risk factors in the pathogenesis of prostate cancer, recent advancement in molecular genetics suggests that genetic heredity plays a crucial role in prostate carcinogenesis. Approximately, 60% of heritability and more than 100 well-recognized single-nucleotide-polymorphisms (SNPs) have been found to be associated with prostate cancer and constitute a major risk factor in the development of prostate cancer. Recent findings revealed that a low to moderate effect on the progression of prostate cancer of individual SNPs was observed compared to a strong progressive effect when SNPs were in combination. Here, in this review, we made an attempt to critically analyze the role of SNPs and associated genes in the development of prostate cancer and their implications in diagnostics and therapeutics. A better understanding of the role of SNPs in prostate cancer susceptibility may improve risk prediction, enhance fine-mapping, and furnish new insights into the underlying pathophysiology of prostate cancer.</description><identifier>ISSN: 1943-8141</identifier><identifier>EISSN: 1943-8141</identifier><identifier>PMID: 34017579</identifier><language>eng</language><publisher>United States: e-Century Publishing Corporation</publisher><subject>Review</subject><ispartof>American journal of translational research, 2021-01, Vol.13 (4), p.3868-3889</ispartof><rights>AJTR Copyright © 2021.</rights><rights>AJTR Copyright © 2021 2021</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8129253/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8129253/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34017579$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Allemailem, Khaled S</creatorcontrib><creatorcontrib>Almatroudi, Ahmad</creatorcontrib><creatorcontrib>Alrumaihi, Faris</creatorcontrib><creatorcontrib>Makki Almansour, Nahlah</creatorcontrib><creatorcontrib>Aldakheel, Fahad M</creatorcontrib><creatorcontrib>Rather, Rafiq Ahmad</creatorcontrib><creatorcontrib>Afroze, Dil</creatorcontrib><creatorcontrib>Rah, Bilal</creatorcontrib><title>Single nucleotide polymorphisms (SNPs) in prostate cancer: its implications in diagnostics and therapeutics</title><title>American journal of translational research</title><addtitle>Am J Transl Res</addtitle><description>Prostate cancer is one of the most frequently diagnosed malignancies in developed countries and approximately 248,530 new cases of prostate cancer are likely to be diagnosed in the United States in 2021. During the late 1990s and 2000s, the prostate cancer-related death rate has decreased by 4% per year on average because of advancements in prostate-specific antigen (PSA) testing. However, the non-specificity of PSA to distinguish between benign and malignant forms of cancer is a major concern in the management of prostate cancer. Despite other risk factors in the pathogenesis of prostate cancer, recent advancement in molecular genetics suggests that genetic heredity plays a crucial role in prostate carcinogenesis. Approximately, 60% of heritability and more than 100 well-recognized single-nucleotide-polymorphisms (SNPs) have been found to be associated with prostate cancer and constitute a major risk factor in the development of prostate cancer. Recent findings revealed that a low to moderate effect on the progression of prostate cancer of individual SNPs was observed compared to a strong progressive effect when SNPs were in combination. Here, in this review, we made an attempt to critically analyze the role of SNPs and associated genes in the development of prostate cancer and their implications in diagnostics and therapeutics. A better understanding of the role of SNPs in prostate cancer susceptibility may improve risk prediction, enhance fine-mapping, and furnish new insights into the underlying pathophysiology of prostate cancer.</description><subject>Review</subject><issn>1943-8141</issn><issn>1943-8141</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNpVkEtLAzEUhYMotlb_gmSpi4E8Ji8XghRfUFRo90Mmk7bRmSQkqdB_b4sP6upc7jn3g3uOwBirmlYS1_j4YB6Bs5zfEeJMcXIKRrRGWDChxuBj7vyqt9BvTG9DcZ2FMfTbIaS4dnnI8Gr-8pavofMwppCLLhYa7Y1NN9CVDN0Qe2d0ccHnfahzeuV3OWcy1L6DZW2TjnazX5yDk6Xus7340QlYPNwvpk_V7PXxeXo3qyLhvFStwNhazTuOWkulrhkjQklGDV-qWnUUYU5aJdqWIEQZVQwRwaUku5-k4HQCbr-xcdMOtjPWl6T7JiY36LRtgnbNf8e7dbMKn43ERBFGd4DLQ8Df5W9r9AtLbGvo</recordid><startdate>20210101</startdate><enddate>20210101</enddate><creator>Allemailem, Khaled S</creator><creator>Almatroudi, Ahmad</creator><creator>Alrumaihi, Faris</creator><creator>Makki Almansour, Nahlah</creator><creator>Aldakheel, Fahad M</creator><creator>Rather, Rafiq Ahmad</creator><creator>Afroze, Dil</creator><creator>Rah, Bilal</creator><general>e-Century Publishing Corporation</general><scope>NPM</scope><scope>5PM</scope></search><sort><creationdate>20210101</creationdate><title>Single nucleotide polymorphisms (SNPs) in prostate cancer: its implications in diagnostics and therapeutics</title><author>Allemailem, Khaled S ; Almatroudi, Ahmad ; Alrumaihi, Faris ; Makki Almansour, Nahlah ; Aldakheel, Fahad M ; Rather, Rafiq Ahmad ; Afroze, Dil ; Rah, Bilal</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p266t-b711eea6d60be38a455279853c6f949d30162b97bb2003539502768820178763</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Review</topic><toplevel>online_resources</toplevel><creatorcontrib>Allemailem, Khaled S</creatorcontrib><creatorcontrib>Almatroudi, Ahmad</creatorcontrib><creatorcontrib>Alrumaihi, Faris</creatorcontrib><creatorcontrib>Makki Almansour, Nahlah</creatorcontrib><creatorcontrib>Aldakheel, Fahad M</creatorcontrib><creatorcontrib>Rather, Rafiq Ahmad</creatorcontrib><creatorcontrib>Afroze, Dil</creatorcontrib><creatorcontrib>Rah, Bilal</creatorcontrib><collection>PubMed</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>American journal of translational research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Allemailem, Khaled S</au><au>Almatroudi, Ahmad</au><au>Alrumaihi, Faris</au><au>Makki Almansour, Nahlah</au><au>Aldakheel, Fahad M</au><au>Rather, Rafiq Ahmad</au><au>Afroze, Dil</au><au>Rah, Bilal</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Single nucleotide polymorphisms (SNPs) in prostate cancer: its implications in diagnostics and therapeutics</atitle><jtitle>American journal of translational research</jtitle><addtitle>Am J Transl Res</addtitle><date>2021-01-01</date><risdate>2021</risdate><volume>13</volume><issue>4</issue><spage>3868</spage><epage>3889</epage><pages>3868-3889</pages><issn>1943-8141</issn><eissn>1943-8141</eissn><abstract>Prostate cancer is one of the most frequently diagnosed malignancies in developed countries and approximately 248,530 new cases of prostate cancer are likely to be diagnosed in the United States in 2021. During the late 1990s and 2000s, the prostate cancer-related death rate has decreased by 4% per year on average because of advancements in prostate-specific antigen (PSA) testing. However, the non-specificity of PSA to distinguish between benign and malignant forms of cancer is a major concern in the management of prostate cancer. Despite other risk factors in the pathogenesis of prostate cancer, recent advancement in molecular genetics suggests that genetic heredity plays a crucial role in prostate carcinogenesis. Approximately, 60% of heritability and more than 100 well-recognized single-nucleotide-polymorphisms (SNPs) have been found to be associated with prostate cancer and constitute a major risk factor in the development of prostate cancer. Recent findings revealed that a low to moderate effect on the progression of prostate cancer of individual SNPs was observed compared to a strong progressive effect when SNPs were in combination. Here, in this review, we made an attempt to critically analyze the role of SNPs and associated genes in the development of prostate cancer and their implications in diagnostics and therapeutics. A better understanding of the role of SNPs in prostate cancer susceptibility may improve risk prediction, enhance fine-mapping, and furnish new insights into the underlying pathophysiology of prostate cancer.</abstract><cop>United States</cop><pub>e-Century Publishing Corporation</pub><pmid>34017579</pmid><tpages>22</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1943-8141
ispartof American journal of translational research, 2021-01, Vol.13 (4), p.3868-3889
issn 1943-8141
1943-8141
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8129253
source PMC (PubMed Central)
subjects Review
title Single nucleotide polymorphisms (SNPs) in prostate cancer: its implications in diagnostics and therapeutics
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T07%3A11%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Single%20nucleotide%20polymorphisms%20(SNPs)%20in%20prostate%20cancer:%20its%20implications%20in%20diagnostics%20and%20therapeutics&rft.jtitle=American%20journal%20of%20translational%20research&rft.au=Allemailem,%20Khaled%20S&rft.date=2021-01-01&rft.volume=13&rft.issue=4&rft.spage=3868&rft.epage=3889&rft.pages=3868-3889&rft.issn=1943-8141&rft.eissn=1943-8141&rft_id=info:doi/&rft_dat=%3Cpubmed%3E34017579%3C/pubmed%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p266t-b711eea6d60be38a455279853c6f949d30162b97bb2003539502768820178763%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/34017579&rfr_iscdi=true